Matroxs Xenia to drive Carestream rad workstations

Clint vanSonnenberg | | Health Imaging | Practice Management
Carestream Health has chosen Matrox Graphics' Xenia Series display controller boards to drive a round of the company's PACS and mammography deployments. Carestream made the announcement at the 96th annual scientific meeting of the Radiologic Society of North America (RSNA) in Chicago.

Xenia and Xenia Pro display controller boards provide triple digital display support from a single slot PCI express board, with forward- and backward-compatibility. According to Montreal-based Matrox, the Xenia Series enable image resolutions of up to 8MP and include 1GB of on-board memory. The display controller boards will be part of Rochester, N.Y.-based Carestream's vendor neutral PACS and mammography workstations.

Clint vanSonnenberg

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.